CAS: 700874-72-2 - Galunisertib

Fórmula: C₂₂H₁₉N₅O

InChI: InChI=1S/C22H19N5O/c1-13-4-2-5-18(25-13)21-20(19-6-3-11-27(19)26-21)15-9-10-24-17-8-7-14(22(23)28)12-16(15)17/h2,4-5,7-10,12H,3,6,11H2,1H3,(H2,23,28)

Chave InChI: InChIKey=IVRXNBXKWIJUQB-UHFFFAOYSA-N

SMILES: O=C(N)C=1C=CC2=NC=CC(=C2C1)C=3C(=NN4C3CCC4)C=5N=C(C=CC5)C

Sinónimos:

• 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide
• 4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide
• 6-Quinolinecarboxamide, 4-[5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-
• Ly-2157299

4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide

CAS: 700874-72-2

• Fórmula: C₂₂H₁₉N₅O
• Pureza: 98%
• Cor e Forma: Solid
• Peso molecular: 369.4192

Galunisertib (LY2157299)

CAS: 700874-72-2

• Fórmula: C₂₂H₁₉N₅O
• Peso molecular: 369.43

LY2157299

CAS: 700874-72-2

• Peso molecular: 369.42g/mol

Galunisertib

CAS: 700874-72-2

Galunisertib (LY2157299) is a selective TGF-β receptor type I (TGF-βRI) inhibitor. Galunisertib has antitumor activity. …

• Fórmula: C₂₂H₁₉N₅O
• Pureza: 100% - 99.98%
• Cor e Forma: Solid
• Peso molecular: 369.42

LY2157299

CAS: 700874-72-2

Applications LY2157299 is a TGF-β type I receptor kinase inhibitor. LY2157299 has been used to …

• Fórmula: C₂₂H₁₉N₅O
• Cor e Forma: Neat
• Peso molecular: 369.42

Galunisertib

CAS: 700874-72-2

• Pureza: 95.0%
• Cor e Forma: Solid
• Peso molecular: 369.4280090332031

LY2157299

CAS: 700874-72-2

Inhibitor of kinase domain of TGF-β receptor type 1

• Fórmula: C₂₂H₁₉N₅O
• Pureza: Min. 95%
• Cor e Forma: Powder
• Peso molecular: 369.42 g/mol